0 //5A R M - I BIOACCUMULATION TEST SUBSTANCE Identity: [2-(N-Ethylperfluorooctanesulfonamido) ethyl acrylate: may also be referred to as B1228, D-1, EtFOSEA, or FX-13. (2-Propenoic acid, 2[ethyl[heptadecafluorooctyl)sulfonyl]amino]ethyl ester, CAS # 423-825) Remarks: Material is an amber solid.

ARMrcm^ MUTAGENICITY EVALUATION OF T-2015 CoC IN THE AMES SALMOREtn/MICROSOME ----------- F CTTE TEST------------- FINAL REPORT SUBMITTED TO: 3M COMPANY 3M CENTER SAINT PAUL, MINNESOTA 55101 DB BIONETICS Utton SUBMITTED BY: LITTON BIONETICS, INC. 5516 NICHOLSON LANE KENSINGTON, MARYLAND 20795 LBI PROJECT NO. 20838 FEBRUARY 1978 C00165 I.

CO RN ING Hazleton MUTAGENICITY TEST WITH T-6564 IN THE SALMONELLA - ESCHERICHIA COI//MAMMALIAN-MICROSOME REVERSE MUTATION ASSAY WITH A CONFIRMATORY ASSAY FINAL REPORT AUTHOR Timothy E.

ACUTE TOXICITY TO FISH AR336-0 W TEST SUBSTANCE Identity: Perfluorooctanoic acid, ammonium salt; may also be referred to as PFOA ammonium salt, Ammonium perfluorooctanoate, PFO, FC116, FC-126, FC-169, orFC-143.

ARXlCrOW THE SCIENCE OF ORGANIC FLUOROCHEMISTRY 3M February 5,1999 000002 The Science of Organic Fluorochemistry Introduction The science of fluorochemistry begins with fluorine.

}r f .T lP * l t r a , S^/ U -l PA-rJT^ l f3 A-ik/TS t- fW } d v ^ - r s . *.

PFOS: A REPRODUCTION STUDY WITH THE NORTHERN BOBWHITE FINAL REPORT WILDLIFE INTERNATIONAL, LTD.

/)/ea~/g5f STUDY TITLE Extraction of Potassium Perfluorooctanesulfonate from Red Blood Cells and Serum for Analysis Using HPLC-Electrospray/Mass Spectrometry DATA REQUIREMENTS Analytical Method Requirements STUDY DIRECTOR Sean Gallagher ANALYTICAL REPORT DATE June 2, 2003 PERFORMING LABORATORY / TESTING FACILITY Exygen Research 3058 Research Drive State College, PA 16801 Phone: 814-272-1039 STUDY SPONSOR 3M Environmental Technology and Safety Services Building 2-3E-09 PO Box 33331 St.

A226r/qo3 SRPT T-6295.8, T-6316.4, T-6868.2, T-7071.1, T-7132.1 DT15-B 3M MEDICAL DEPARTMENT, CORPORATE TOXICOLOGY Title: Comparative Molecular Biology of Perfluorooctanesulfonate (PFOS, T-6295), N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE, T-6316), N-Ethyl perfluorooctanesulfonamide (N-EtFOSA, T-6868), Perfluorooctanesulfonamido acetate (FOSAA, T-7071), and/or Perfluorooctanesulfonamide (FOSA, T-7132) of in Rats and Guinea Pigs following Oral dosing.

CO h- o CMi CO CM CM O < ?

AR226-2151 To: Andrea Malinow ski/DPL/DUP@ DUP, Bernard J Reilly/AE/DuPont@DuPont, Stephen H Korzeniowski/DuPont@DuPont, Jim E Pesek/AE/DuPont@DuPont, Robert C Buck/DuPont@DuPont.

AR226-2244 Thompson Collins Watkins Smith _______________________________ Name_____________________________________ Concentrations are from the deposition modeling runs, and Include wet and dry depletion due to deposition EDDOO6 5 8 3 3 Particulate Vapor Total Deposition Deposition Deposition Coordinates (q/m2/yr) (q/m2/yr) (g/m2/yr) 445213E 4346090N 443141E 4345753N 443223E 4345847N 443254E 4345S88N 0.00098 0.00179 0.00193 0.00186 0.00008 0.00021 0.00019 0.00018 0.00106 0.00200 0,00212 0.00204 Particulate Vapor Total Concentration Concentration Concentration (ug/m3) iu g /m 3) (ug/m3) 0.02000 0.03217 0.05217 0.037S2 0.05854 0.09606 0.03665 0.05695 0.09360 0.03554 0.05587 0,09141 EDDO O6 5 8 3 4

AR226-2297 David M Rurak 02/10/2003 06:52 PM To: Seiichi Tanaka/PO/DuPont@DuPont cc: Ta-Wei Fu/CL/DuPont@DuPont, Hidetaka Hiromatsu/PO/DuPont@DuPont, Katsunosuke Kitagawa/PO/DuPont@DuPont, Kazuaki Suzuki/PO/DuPont@DuPont, Akito Abe/AE/DuPont@DuPont, Catherine A Barton/AE/DuPont@DuPont Subject: R e : CEG Calculation at Shimizu Site D Tanaka-san, Please allow me to clarify a couple of items: 1) First of all, the C E G is not calculated for a plant site.

APPENDIX 2 AR226-2379 ANALYTICAL TECHNIQUE USED TO DETERMINE C-8 CONCENTRATION IN AQUEOUS SOLUTION The basis for the analytical technique used to determine the C-8 concentration in an aqueous solution was Polymer Products Department method Code No.

AR226-2403 v INTEROFFICE MEMORANDUM Date; From* Dept; Tel No; 7-JU1-1989 OlS02pm WILLIAM E CRAWLEY CRAWLEWE FPD-#TEFLON',TECH 304-8S3-2742 Howard A.